Sign inJoin waitlistJoin the waitlist

Heidi Jacobe

Director of the CTSA Workforce Development Core · University of Texas Southwestern Medical Center

Credentials: · · ·

History

CTSA Workforce Development Core · University of Texas Southwestern Medical Center
Present
Master of Clinical Science Program · University of Texas Southwestern Medical Center
Present
University of Texas Southwestern Medical Center
Present

Dermatology
University of Texas Southwestern Medical Center
1997–2000
Internal Medicine
Baylor College of Medicine
1996–1997
Baylor College of Medicine
1992–1996

Research

Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin
Journal of Investigative Dermatology · 1997 · 244 citations
Sertraline as a first-line treatment for cholestatic pruritus
Hepatology · 2007 · 216 citations
Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases
Archives of Dermatology · 2009 · Last of 6 authors · 164 citations

Kathryn Torok
15 papers
SP
Smriti Prasad
12 papers
Henry Chen
11 papers · 2 as a resident
JZ
Jane Zhu
8 papers · 8 as a resident
NT
Noelle Teske
8 papers · 3 as a resident
Adrienne Joseph
7 papers · 3 as a resident
EK
Elaine Kunzler
7 papers · 7 as a resident
Stephanie Savory
7 papers
Jack O'Brien
6 papers · 4 as a resident
JL
Justin Leitenberger
6 papers
Laila Abbas
6 papers · 2 as a resident
Rebecca Vasquez
5 papers · 1 as a resident

Grants

Establishing and Validating Outcome Measures for Craniofacial Morphea Across the Lifespan
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $222.4K · Ut Southwestern Medical Center
2026–2030
Ancillary Studies to Define Dysregulated Immune and Fibrotic Pathways in a Well-Characterized Morphea Cohort
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
PI · $1.4M · University of Pittsburgh at Pittsburgh
2021–2025
Refining Outcome Measures Through Observational Cohorts to Advance Trials in Morphea
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $640.5K · Ut Southwestern Medical Center
2019–2023
Defining Dysregulated Immune and Fibrotic Pathways in Morphea
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R56
PI · $289.1K · University of Pittsburgh at Pittsburgh
2019–2021

Clinical trials

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
Principal investigator · Completed
University of Texas Southwestern Medical Center
2012–2019
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Principal investigator · Recruiting
University of Texas Southwestern Medical Center
2007–2028
Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Principal investigator · Completed
University of Texas Southwestern Medical Center
2004–2009